Jan Cools
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Jan Cools
Jul 14, 2024, 07:13 |
Blog
The main scientific topics of ESHALL2025
ESH (European School of Haematology) shared a post on X: ''The main scientific topics of…
Jul 4, 2024, 08:53 |
Blog
Jan Cools: 2023 journal impact factor of HemaSphere Journal is 12.1
Jan Cools, Editor in Chief of HemaSphere, journal of EHA at European Hematology Association (EHA), made…
Mar 9, 2024, 14:13 |
Insight
Jan Cools: A single-cell expression atlas of 119,000 AML cells and AML stem cells in paired diagnostic-relapse samples
Jan Cools, Editor in Chief of HemaSphere, journal of EHA at European Hematology Association (EHA), shared…
Sep 9, 2023, 20:36 |
Blog
Jan Cools: I am very excited to announce an update on the 2022 journal impact factor of Hema Sphere Journal - the new projected impact factor is 9.1 and will be released by Clarivate in the October JCR update.
All:
4
Posts:
1 - 100
ESTRO: Everything You Need to Know About European Society for Radiotherapy and Oncology
Jane Fonda Breast Cancer and Non-Hodgkin Lymphoma: How She Went Against, How She Survived, and More
Inside OncoDaily Party Barcelona
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube